Cardiac troponins can be useful in monitoring cardiac injury following perinatal distress. We report here an increase of cardiac troponin I (cTnI) to 2.84 microg/l at 3 weeks (age-related median: 0.07 microg/l) followed by normalization in a newborn with an uneventful clinical course after resuscitation at birth. Serial echocardiographs showed normal cardiac function. Such a time course of cTnI, not previously reported, could be due to either a greater sensitivity of biochemical markers than of instrumental tools or birth asphyxia. Larger studies are neede
BACKGROUND:Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyt...
Neonatal myocardial dysfunction may impact negatively on survival outcomes in preterm and term infan...
Objective: The objective of this study is to evaluate the presence and severity of cardiac involveme...
Aim: Myocardial dysfunction is a frequent sequel of perinatal asphyxia. Cardiac troponin I (cTnI) is...
AIM: To assess the correlation of echocardiographic signs of myocardial damage to serum cardiac trop...
Introduction: Resource limitation in developing countries may preclude access to cardiac troponin-T ...
Introduction: Cardiac dysfunction is well known in perinatal asphyxia caused by transit myocardial i...
Background: Cardiac troponins T (cTnT) and I (cTnI) are well-established markers in detecting myocar...
BACKGROUND: Perinatal asphyxia is one of the leading causes of neonatal mortality and important cau...
Objective: Neonates produce predominantly skeletal muscle troponin I (Tnl) in the myocardium,- howev...
Introduction: In the last few years the use of cardiac troponin I and T, as diagnostic and prognosti...
Objective Low-cost diagnostic and prognostic biomarkers could help guide clinical management of neon...
Introduction: Perinatal asphyxia has effect on various body system and cardiovascular system is one ...
Purpose. To assess frequency and severity of myocardial damage in premature infants with transient m...
Objectives: It has been proposed that an elevated concentration of cardiac troponin in umbilical cor...
BACKGROUND:Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyt...
Neonatal myocardial dysfunction may impact negatively on survival outcomes in preterm and term infan...
Objective: The objective of this study is to evaluate the presence and severity of cardiac involveme...
Aim: Myocardial dysfunction is a frequent sequel of perinatal asphyxia. Cardiac troponin I (cTnI) is...
AIM: To assess the correlation of echocardiographic signs of myocardial damage to serum cardiac trop...
Introduction: Resource limitation in developing countries may preclude access to cardiac troponin-T ...
Introduction: Cardiac dysfunction is well known in perinatal asphyxia caused by transit myocardial i...
Background: Cardiac troponins T (cTnT) and I (cTnI) are well-established markers in detecting myocar...
BACKGROUND: Perinatal asphyxia is one of the leading causes of neonatal mortality and important cau...
Objective: Neonates produce predominantly skeletal muscle troponin I (Tnl) in the myocardium,- howev...
Introduction: In the last few years the use of cardiac troponin I and T, as diagnostic and prognosti...
Objective Low-cost diagnostic and prognostic biomarkers could help guide clinical management of neon...
Introduction: Perinatal asphyxia has effect on various body system and cardiovascular system is one ...
Purpose. To assess frequency and severity of myocardial damage in premature infants with transient m...
Objectives: It has been proposed that an elevated concentration of cardiac troponin in umbilical cor...
BACKGROUND:Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyt...
Neonatal myocardial dysfunction may impact negatively on survival outcomes in preterm and term infan...
Objective: The objective of this study is to evaluate the presence and severity of cardiac involveme...